I can understand the frustration with lack of reliable CRM data but the solution is not to abandon analytics but to change the incentives for field force data capture.
I can understand the frustration with lack of reliable CRM data but the solution is not to abandon analytics but to change the incentives for field force data capture. With intense pressure to perform at a time when physician access is poor there is small wonder that salesmen are tempted to "cheat". We all know that sales output is ultimately what counts not call types, frequency and target inputs. Obviously you dont get sales ooutput without some inputs and the temptation for FLSMs to manage via input KPIs is overwhelming - what else can he/she influence? Actually, quite a lot! With robust analytics (and i dont mean time series regression from an excel spreadsheet) patterns of activity of sales reps can be discerned which are distinct from other patterns - so much so that they can be regarded as separate strategies within a salesforce. These separate strategies can be linked to degrees of sales success and templates of successful activity can be used to migrate the behaviour of poorer performing reps to that of better performing reps. This brings us full circle to reliability of the data input. But once a field force can see that their compensation can be accurately calculated from the combination of sales outputs and behavioural inputs they should respond positively to encouragement to capture inputs honestly. Robust analytics can even differentiate sales contributions between reps in mirror territories - an absolute godesend for managers looking to determine the impact of a contract or co-promotion force.
blog comments powered by DisqusKevin Appareti, global director for Medical Science Liaison at Philips Healthcare, explains how to motivate KOLs and how to measure their value
The Mobile Health Competition is now closed, but the journey is just beginning for the winning idea.
Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs